OPKO Health Inc (NAS:OPK)
$ 1.55 -0.03 (-1.9%) Market Cap: 1.04 Bil Enterprise Value: 1.17 Bil PE Ratio: 0 PB Ratio: 0.75 GF Score: 42/100

OPKO Health Inc at JPMorgan Healthcare Conference (Virtual) Transcript

Jan 13, 2021 / 08:40PM GMT
Release Date Price: $4.44 (-0.67%)
Timothy Donnally
JP Morgan Chase & Co. - Healthcare Investment Banking Associate

Good afternoon and thank you all for joining us today. My name is Tim Donnally. I'm a member of the JPM Healthcare Investment Banking team. It is my pleasure to introduce our speakers for today's session from the management team of OPKO Health, including Dr. Phil Frost; and Jon Cohen; Steve (technical difficulty). With that, I will pass it off to Phil Frost. Phil?

Phillip Frost
OPKO Health, Inc. - Chairman & CEO

So we are really pleased to present this year at the JPM conference. The OPKO story has evolved over the last year to the point where I think you're going to find it especially interesting. And we're going to start off with our speakers here in Miami, and we will start with Steve and then go on to Adam, and then move on to Jon to tell the BioReference story.

Steve Rubin?

Steven D. Rubin
OPKO Health, Inc. - Executive VP of Administration & Director

Thank you. Hello, everyone. So as Phil mentioned, we'll

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot